Affordable Access

Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy.

Authors
Type
Published Article
Journal
Cancer research
Publication Date
Volume
64
Issue
5
Pages
1867–1874
Identifiers
PMID: 14996751
Source
Medline

Abstract

Statistics

Seen <100 times